Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Grace Therapeutics, Inc. GRCE

Set alert

Price alert · GRCE

All alert types
1.81 USD -0.13 -6.70%

At close · Nov 2

1.81 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
1.77 × 2
Ask
1.84 × 2
1.76 Day range 1.95
1.67 52-week range 5.18
YTD
-47.69%
1 year
-42.72%
Open
1.93
Prev close
1.94
Mkt cap
38.08M
Vol
99.54K
Avg vol
138.44K
EPS
-1.17
P/E
0.00
Div yield
0.00%
More statistics
Low
1.76
High
1.95
Forward P/E
-2.90
Beta
1.51
Short ratio
3.25
Inst. own
21.39%
Dividend
0.00
Ex-div date
Earnings
Feb 10, 2025
50-d avg
3.44
200-d avg
3.04
1y target
10.44

3M chart

Chart tools
Interval
1m5m15m30m

Signals (10)
NameDateAgo
MACD: Buy SignalOct 28, 20265 days ago
SMA: BearishSep 25, 20261 month ago
SMA: BullishSep 24, 20261 month ago
MACD: Sell SignalSep 21, 20261 month ago
SMA: BearishSep 16, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 11, 20261 month ago
SMA: BullishSep 10, 20261 month ago
SMA: BullishSep 9, 20261 month ago
MACD: Buy SignalAug 14, 20262 months ago

Financial health

Altman Z-Score

5.07 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -9.9×
FY 2017: -0.1×FY 2018: -0.1×FY 2019: -0.1×FY 2020: -0.1×FY 2021: -0.3×FY 2022: -1.5×FY 2023: -0.4×FY 2024: -1.6×FY 2025: -2.0×FY 2026: -9.9×
FY 2017 5y median -1.6× FY 2026
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 30.2×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 1.2×
FY 2017: 0.0×FY 2018: 0.2×FY 2019: 0.4×FY 2020: 0.4×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.5×FY 2025: 0.4×FY 2026: 1.2×
FY 2017 5y median 0.4× FY 2026
P/FCF -8.6×
FY 2017: -0.1×FY 2018: -0.1×FY 2019: -0.2×FY 2020: -0.2×FY 2021: -0.5×FY 2022: -1.1×FY 2023: -1.4×FY 2024: -2.3×FY 2025: -1.8×FY 2026: -8.6×
FY 2017 5y median -1.8× FY 2026
EV/EBITDA -5.4×
FY 2017: -0.3×FY 2018: 0.3×FY 2019: 0.3×FY 2020: 0.3×FY 2021: 3.5×FY 2022: 0.6×FY 2023: 0.2×FY 2024: -0.4×FY 2025: -0.2×FY 2026: -5.4×
FY 2017 5y median -0.2× FY 2026
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -176×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -11.6%
FY 2017: -1026.5%FY 2018: -710.6%FY 2019: -557.2%FY 2020: -441.1%FY 2021: -193.4%FY 2022: -93.2%FY 2023: -71.2%FY 2024: -43.1%FY 2025: -54.1%FY 2026: -11.6%
FY 2017 5y median -54.1% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 61.2%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -8377.1%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -10039.8%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -12.2%
FY 2017: -48.6%FY 2018: -261.5%FY 2019: -356.4%FY 2020: -277.5%FY 2021: -44.4%FY 2022: -11.3%FY 2023: -84.4%FY 2024: -28.2%FY 2025: -20.5%FY 2026: -12.2%
FY 2017 5y median -20.5% FY 2026
ROIC -14.1%
FY 2017: -44.6%FY 2018: -121.1%FY 2019: -139.9%FY 2020: -221.2%FY 2021: -33.8%FY 2022: -14.6%FY 2023: -76.0%FY 2024: -21.3%FY 2025: -25.4%FY 2026: -14.1%
FY 2017 5y median -21.3% FY 2026
ROA -11.7%
FY 2017: -41.4%FY 2018: -93.7%FY 2019: -106.7%FY 2020: -157.8%FY 2021: -39.6%FY 2022: -9.5%FY 2023: -72.5%FY 2024: -23.8%FY 2025: -18.9%FY 2026: -11.7%
FY 2017 5y median -18.9% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income 53.4%
FY 2017: -7.1%FY 2018: -44.9%FY 2019: -125.6%FY 2020: -41.9%FY 2021: 46.9%FY 2022: 24.8%FY 2023: -262.2%FY 2024: 75.3%FY 2025: -36.2%FY 2026: 53.4%
FY 2017 FY 2026
EPS (diluted) 58.4%
FY 2017: -54.9%FY 2018: -29.8%FY 2019: 21.5%FY 2020: 38.2%FY 2021: 56.3%FY 2022: 84.0%FY 2023: -282.2%FY 2024: 76.3%FY 2025: 38.3%FY 2026: 58.4%
FY 2017 FY 2026
Free Cash Flow 40.5%
FY 2017: -85.7%FY 2018: -5.6%FY 2019: -152.0%FY 2020: -29.9%FY 2021: 45.1%FY 2022: 4.7%FY 2023: 7.6%FY 2024: 22.4%FY 2025: -20.6%FY 2026: 40.5%
FY 2017 FY 2026

Financial Health

Current Ratio 8.1×
FY 2017: 4.8×FY 2018: 1.4×FY 2019: 2.0×FY 2020: 2.2×FY 2021: 39.5×FY 2022: 14.0×FY 2023: 8.6×FY 2024: 14.3×FY 2025: 11.8×FY 2026: 8.1×
FY 2017 5y median 11.8× FY 2026
Quick Ratio 8.1×
FY 2017: 4.8×FY 2018: 1.4×FY 2019: 2.0×FY 2020: 2.2×FY 2021: 39.5×FY 2022: 14.0×FY 2023: 8.6×FY 2024: 14.3×FY 2025: 11.8×FY 2026: 8.1×
FY 2017 5y median 11.8× FY 2026
Debt / Equity 0.0×
FY 2017: 0.1×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 1.5×
FY 2017: -0.2×FY 2018: 0.4×FY 2019: 0.4×FY 2020: 0.4×FY 2021: 4.1×FY 2022: 1.6×FY 2023: 1.1×FY 2024: 1.5×FY 2025: 0.9×FY 2026: 1.5×
FY 2017 5y median 1.5× FY 2026
Interest Coverage 0.0×
FY 2017: -193×FY 2018: -41.0×FY 2019: -32.7×FY 2020: -118×FY 2021: -78.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-31